Salaires et Rémunération chez Healx

Healx is a Cambridge-based HealthTech company founded in 2014 that uses generative AI and machine learning to accelerate drug discovery and development for rare diseases — conditions affecting fewer than 5 in 10,000 people for which effective treatments often don't exist. Its AI platform combines biomedical knowledge graphs, patient data, and multi-modal learning to identify and repurpose existing approved drugs as novel treatments for rare disease indications, dramatically compressing the time and cost of bringing new therapies to patients. With $47 million raised in Series C and FDA clearance for a Phase 2 clinical trial, Healx is translating AI-powered drug discovery into real-world clinical impact for rare disease communities worldwide.